Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Calcitriol 250nanogram capsules
0906040C0AAAAAA
|
Calcitriol | Calcitriol | Nutrition and Blood | 7,354 |
|
Silkis ointment
1305020W0BBAAAA
|
Silkis | Calcitriol | Skin | 3,497 |
|
Calcitriol 500nanogram capsules
0906040C0AAABAB
|
Calcitriol | Calcitriol | Nutrition and Blood | 3,321 |
|
Calcitriol 3micrograms/g ointment
1305020W0AAAAAA
|
Calcitriol (Psoriasis) | Calcitriol | Skin | 2,762 |
|
Rocaltrol 500nanogram capsules
0906040C0BBABAB
|
Rocaltrol | Calcitriol | Nutrition and Blood | 391 |
|
Rocaltrol 250nanogram capsules
0906040C0BBAAAA
|
Rocaltrol | Calcitriol | Nutrition and Blood | 245 |
|
Calcijex 1micrograms/1ml solution for injection ampoules
0906040C0BCABAE
|
Calcijex | Calcitriol | Nutrition and Blood | No data available |
|
Calcijex 2micrograms/1ml solution for injection ampoules
0906040C0BCAAAD
|
Calcijex | Calcitriol | Nutrition and Blood | No data available |
|
Calcitriol 1micrograms/1ml solution for injection ampoules
0906040C0AAAEAE
|
Calcitriol | Calcitriol | Nutrition and Blood | No data available |
|
Calcitriol 2micrograms/1ml solution for injection ampoules
0906040C0AAADAD
|
Calcitriol | Calcitriol | Nutrition and Blood | No data available |
|
Calcitriol 500nanograms/5ml oral liquid
0906040C0AAAGAG
|
Calcitriol | Calcitriol | Nutrition and Blood | No data available |
|
Calcitriol 5micrograms/5ml oral liquid
0906040C0AAAIAI
|
Calcitriol | Calcitriol | Nutrition and Blood | No data available |
|
Rocaltrol 1micrograms/ml oral solution
0906040C0BBACAI
|
Rocaltrol | Calcitriol | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.